slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
225,181-225,240 of 319,975
27
The chart uses a stacked bar approach to show the components of FX impact.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
28
The slide uses a standard financial reporting table format to highlight debt metrics.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
29
The slide uses a house-like structure to represent the capital allocation framework.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
30
The chart uses a standard waterfall bridge to decompose the change in EPS.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
31
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
32
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a hierarchical structure to connect high-level purpose to operational execution.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
34
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
35
The table uses a waterfall-style logic to bridge operating profit figures.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
36
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
37
This is a continuation of a financial disclosure page from a Diageo interim results report.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
38
This slide is part of a series of methodological disclosures, likely from an annual or interim report.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
39
This is a continuation of a methodology disclosure page.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
01
Features imagery from EA Sports titles (NHL, UFC, WRC).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
02
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
03
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
04
The slide uses a 2x3 grid layout to present key performance indicators.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · What IsLoop · Benchmark Gap1 hit
05
The slide uses stacked bar charts to show revenue composition over three periods (Q3 FY22-FY24).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · What IsLoop · Benchmark Gap1 hit
06
Includes YoY and YoY constant currency (CC) growth metrics.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · What IsLoop · Benchmark Gap1 hit
07
The slide uses a legend to distinguish between annual full game releases and new title releases in FY24.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · What IsLoop · Benchmark Gap1 hit
08
Includes specific disclaimers regarding EPS calculation and asset impairment.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
09
Includes a stylized character illustration on the right side.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · What IsLoop · Why Now1 hit
10
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
11
The table provides a reconciliation of GAAP guidance to adjusted figures for the three months ending March 31, 2024.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
12
The table reconciles GAAP guidance ranges with specific non-GAAP adjustments.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
13
Includes definition of Free Cash Flow in the footer.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
14
The slide provides specific FX rate assumptions for EUR, GBP, CAD, and SEK for Q3 2023, Q3 2024, and Q4E 2024, along with sensitivity analysis for a 10% USD strengthening.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
15
The slide presents two separate tables: one for Q4 and one for the full year, detailing the impact of currency on year-over-year growth rates.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
16
Includes two separate tables: one by platform (Console, PC, Mobile) and one by product type (Full game, Live services).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
17
Standard financial disclosure slide for Electronic Arts.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
02
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
03
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
04
The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
05
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
06
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
07
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
09
Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The diagram uses a funnel-like or layered process flow to map biological mechanisms to specific immune outcomes.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
12
The slide uses a process flow diagram to illustrate the 8-step manufacturing timeline.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The slide uses a red border to highlight the RENB-DC11 row as the superior alternative.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The diagram illustrates a complex supply chain process involving biopsy, manufacturing, and clinical administration.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a combination of a process diagram and dot plots to validate the model's performance.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
The slide presents two bar charts (weight and volume) and a grid of tumor photographs as visual proof of concept.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
Includes visual evidence of tumor size alongside quantitative bar charts with statistical significance markers.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The table shows 0/3 incidence of metastasis/ascites in the RENB-DC11 group compared to high incidence in control groups.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
The slide presents two bar charts comparing control, tumor, tumor+mock, and tumor+TD groups under different treatment conditions (IL2 vs aCD16).Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
N=2-3 sample size indicated at bottom left.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
The slide demonstrates efficacy of RENB-DC11 in stimulating immune response (IFNg production) in a tumor model.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
This is a standard TPP (Target Product Profile) table used in biotech/pharma pitch decks.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
25
The slide outlines a clinical development plan with specific milestones for 2025 and 2026, focusing on safety and efficacy cohorts.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
26
The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
27
Standard corporate legal disclosure slide.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Setup1 hit
02
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Setup1 hit